Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

Good afternoon, ladies and gentlemen, and welcome everyone to the Maravai Life Sciences third-quarter 2024 earnings conference call. (Operator Instructions) I would now like to turn the call over to ...

Maravai Lifesciences Holdings, Inc. ( (MRVI) ) has released its Q3 earnings. Here is a breakdown of the information Maravai Lifesciences ...

Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative Nucleic Acid R&DSAN DIEGO, Calif., ...

NTx senior leadership will attend a lineup of industry conferences throughout November and December to preview its NTxscribe system ...

plug and play continuous flow mRNA IVT and purification system ahead of its full commercial launch. NTxscribe is a first-of-its-kind IVT system that enables the production of RNA in a fraction of ...

Get a first look at NTxscribe ®, a continuous flow mRNA in vitro transcription and ... to the market NTxscribe is a first-of-its-kind IVT system that enables the production of RNA in a fraction ...

Join us as we offer two compelling case studies showcasing the remarkable flexibility of Aldevron’s mRNA process development ... to achieve a 95% increase in IVT yield and a 50% improvement ...

Or sign-in if you have an account. An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung cancer. BNT116 is a striking example ...